Defibrotide for the Treatment of Severe Hepatic Veno-Occlusive Disease in Hematopoetic Stem Cell Transplant Patients

Hepatic venoocclusive disease

Efficacy of N-acetylcysteine Versus Placebo as Prophylaxis of Sinusoidal Obstruction Syndrome in Patients Undergoing Hematopoietic Stem Cell Transplantation Pediatric Trial Investigating the Incidence & Outcome of Veno-Occlusive Disease With the Prophylactic Use of Defibrotide Liver Stiffness Measurement Predicts VOD/SOS Development (ELASTOVOD ITALIAN MULTICENTRIC STUDY) Ultrasound Elastography to Predict Development of SOS 5-day Defibrotide Treatment for Hepatic SOS/VOD European VOD Registry Sinusoidal Obstruction Syndrome for Stem Cell Transplant Patients Biomarker Study Prevention of the Hepatic Sinusoidal Obstruction Syndrome by Means of Anticoagulants Validating Ultrasound Biomarkers for Hepatic Sinusoidal Obstruction Syndrome in Pediatric Hematopoietic Cell Transplant Patients Using Ultrasound Elastography to Predict Development of Hepatic Sinusoidal Obstruction Syndrome Study Comparing Efficacy and Safety of Defibrotide vs Best Supportive Care in the Prevention of Hepatic Veno-Occlusive Disease in Adult and Pediatric Patients Antithrombin-III for Patients With Hepatic Veno-occlusive Diseases Following Hematopoietic Stem Cell Transplantation Detection of Sinusoidal Obstruction Syndrome With Ultrasound After Allogeneic HSCT Defibrotide for Patients With Hepatic Veno-occlusive Disease: A Treatment IND Study Compassionate Use of Defibrotide for Patients With Veno-occlusive Disease of the Liver Defibrotide for the Treatment of Severe Hepatic Veno-Occlusive Disease in Hematopoetic Stem Cell Transplant Patients